| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Annals of Surgical Oncology, Vol 6, Issue 3 232-240, Copyright © 1999 by Society of Surgical Oncology
ARTICLES |
S. C. Bieligk, R. Ghossein, S. Bhattacharya and D. G. Coit
Department of Surgery, University of Texas Southwestern Medical Center at Dallas, 75235-9155, USA.
BACKGROUND: Sentinel lymph node (SLN) biopsy is an alternative to elective dissection or observation for management of lymph node basins in patients with cutaneous melanomas. The detection of tyrosinase mRNA in melanoma SLN specimens by reverse transcription-polymerase chain reaction (RT-PCR) has been reported to be a more sensitive method to detect subclinical metastases, compared with histological analysis. The aims of this study were to (1) define the yield of RT-PCR in assessing SLNs, compared with histological analysis, (2) identify the incidence of false-positive results in SLNs, and (3) report the rate of actin PCR negativity (i.e., samples with degraded RNA) in SLNs. METHODS: Twenty-eight patients with 1.2-9.6-mm cutaneous melanomas underwent SLN biopsy (between October 1996 and March 1997). One half of each SLN was analyzed by nested RT-PCR for tyrosinase mRNA. The other half of the SLN was examined by routine microscopy. Twenty-one lymph nodes from patients without melanoma were evaluated as controls. RESULTS: Two of the 28 patients with melanoma were excluded because of RNA degradation, as indicated by actin negativity. Six of the remaining 26 patients exhibited melanoma metastases in routine histological examinations. All histologically positive lymph nodes were RT-PCR-positive. Thirteen of the 20 (65%) histologically negative cases were RT-PCR-positive. Of 21 control lymph nodes, 3 were actin-negative and were not assessable for tyrosinase mRNA. Two of the remaining 18 (11%) negative-control nodes were RT-PCR-positive. CONCLUSIONS: Among patients undergoing SLN biopsy, tyrosinase mRNA was detectable in 73% of SLNs from patients at risk for regional nodal metastases, including all of those with histologically positive SLNs. There is a definable false-positive rate for tyrosinase mRNA detection in the lymph nodes of patients who do not have melanoma. Actin verification of RNA integrity is necessary to ensure the accuracy of this test in detecting tyrosinase mRNA. Ongoing follow-up monitoring will define the prognostic value of this assay.
This article has been cited by other articles:
![]() |
M G Cook and S Di Palma Pathology of sentinel lymph nodes for melanoma J. Clin. Pathol., August 1, 2008; 61(8): 897 - 902. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. P. White, C. I. Barry, and J. W. Patterson Focus-Floating Microscopy for Detecting Borrelia Species in Tissue Sections: Back to Basics Arch Dermatol, May 1, 2008; 144(5): 662 - 663. [Full Text] [PDF] |
||||
![]() |
T. G. Zogakis, R. Essner, H.-j. Wang, R. R. Turner, Y. T. Takasumi, R. L. Gaffney, J. H. Lee, and D. L. Morton Melanoma Recurrence Patterns After Negative Sentinel Lymphadenectomy Arch Surg, September 1, 2005; 140(9): 865 - 872. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Ulmer, J. R. Fischer, S. Schanz, K. Sotlar, H. Breuninger, K. Dietz, G. Fierlbeck, and C. A. Klein Detection of Melanoma Cells Displaying Multiple Genomic Changes in Histopathologically Negative Sentinel Lymph Nodes Clin. Cancer Res., August 1, 2005; 11(15): 5425 - 5432. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. N. Abrahamsen, B. Sandahl Sorensen, E. Nexo, S. J. Hamilton-Dutoit, J. Larsen, and T. Steiniche Pathologic Assessment of Melanoma Sentinel Nodes: A Role for Molecular Analysis Using Quantitative Real-Time Reverse Transcription-PCR for MART-1 and Tyrosinase Messenger RNA Clin. Cancer Res., February 15, 2005; 11(4): 1425 - 1433. [Abstract] [Full Text] [PDF] |
||||
![]() |
U. S. Kammula, R. Ghossein, S. Bhattacharya, and D. G. Coit Serial Follow-Up and the Prognostic Significance of Reverse Transcriptase-Polymerase Chain Reaction--Staged Sentinel Lymph Nodes From Melanoma Patients J. Clin. Oncol., October 1, 2004; 22(19): 3989 - 3996. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Kawada, M. Sonoshita, H. Sakashita, A. Takabayashi, Y. Yamaoka, T. Manabe, K. Inaba, N. Minato, M. Oshima, and M. M. Taketo Pivotal Role of CXCR3 in Melanoma Cell Metastasis to Lymph Nodes Cancer Res., June 1, 2004; 64(11): 4010 - 4017. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. M. Pawlik, M. I. Ross, and J. E. Gershenwald Lymphatic Mapping in the Molecular Era Ann. Surg. Oncol., April 1, 2004; 11(4): 362 - 374. [Full Text] [PDF] |
||||
![]() |
C. T. Kuo, D. S.B. Hoon, H. Takeuchi, R. Turner, H.-J. Wang, D. L. Morton, and B. Taback Prediction of Disease Outcome in Melanoma Patients by Molecular Analysis of Paraffin-Embedded Sentinel Lymph Nodes J. Clin. Oncol., October 1, 2003; 21(19): 3566 - 3572. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. J. Busam Advances in Molecular Staging of Melanoma Patients: Multimarker Analysis of Archival Lymph Node Tissue J. Clin. Oncol., October 1, 2003; 21(19): 3550 - 3551. [Full Text] [PDF] |
||||
![]() |
V Davids, S H Kidson, and G S Hanekom Accurate molecular detection of melanoma nodal metastases: an assessment of multimarker assay specificity, sensitivity, and detection rate Mol. Pathol., February 1, 2003; 56(1): 43 - 51. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Mariani, M. Gipponi, L. Moresco, G. Villa, M. Bartolomei, G. Mazzarol, M. C. Bagnara, A. Romanini, F. Cafiero, G. Paganelli, et al. Radioguided Sentinel Lymph Node Biopsy in Malignant Cutaneous Melanoma* J. Nucl. Med., June 1, 2002; 43(6): 811 - 827. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. E. Wiley, E. B. Gonzalez, W. Maki, M.-t. Wu, and S. T. Hwang Expression of CC Chemokine Receptor-7 and Regional Lymph Node Metastasis of B16 Murine Melanoma J Natl Cancer Inst, November 7, 2001; 93(21): 1638 - 1643. [Abstract] [Full Text] [PDF] |
||||
![]() |
P J Ell A revolution in surgical oncology: sentinel lymph node biopsy Imaging, September 1, 2001; 13(3): 197 - 205. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. A. Ghossein, S. Bhattacharya, and J. Rosai Molecular Detection of Micrometastases and Circulating Tumor Cells in Solid Tumors Clin. Cancer Res., August 1, 1999; 5(8): 1950 - 1960. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |